Package Leaflet: Information for the User
PHYSIONEAL 40 Glucose 1.36% w/v/ 13.6 mg/ml, Solution for Peritoneal Dialysis
PHYSIONEAL 40 Glucose 2.27% w/v/ 22.7 mg/ml, Solution for Peritoneal Dialysis
PHYSIONEAL 40 Glucose 3.86% w/v/ 38.6 mg/ml, Solution for Peritoneal Dialysis
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack:
PHYSIONEAL 40 is a solution for peritoneal dialysis. It removes water and waste products from the blood. It also corrects abnormal levels of various blood components.
PHYSIONEAL 40 contains different concentrations of glucose (1.36%, 2.27%, or 3.86%). The higher the glucose concentration of the solution, the more water will be removed from the blood.
PHYSIONEAL 40 may be prescribed for you if you have:
The PHYSIONEAL 40 solution has an acidity (pH) similar to that of blood. For this reason, it may be particularly useful if you experience discomfort or pain during the administration of other more acidic peritoneal dialysis solutions.
Your doctor should supervise the administration of this product if it is the first time you are using it.
Do not use PHYSIONEAL 40
or an uncorrectable condition that increases the risk of abdominal infections
Warnings and precautions
Consult your doctor before starting to use PHYSIONEAL 40.
Be particularly cautious:
Interaction with other medicines
Tell your doctor if you are using or have recently used other medicines, including those obtained without a prescription.
If you use other medicines, your doctor may need to increase your dose since peritoneal dialysis treatment increases the elimination of certain medicines.
Be careful if you use heart medicines called cardiac glycosides (e.g., digoxin), you may:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medicine. The use of Physioneal is not recommended during pregnancy or breastfeeding unless your doctor advises you to do so.
Driving and using machines
This treatment can cause weakness, blurred vision, or dizziness. Do not drive or use machines if you are affected.
PHYSIONEAL 40 should be administered into your peritoneal cavity. This cavity is located in the abdomen (belly) between the skin and the peritoneum. The peritoneum is the membrane that surrounds the internal organs, such as the intestines or liver.
Do not use intravenously.
Follow exactly the administration instructions of this medicine indicated by the medical team specialized in peritoneal dialysis. If in doubt, consult them again.
If the bag is damaged, it should be discarded.
Dose and frequency
Your doctor will indicate the appropriate glucose concentration and the number of bags you should use each day.
Use in children and adolescents
If you are under 18 years of age, your doctor will carefully evaluate the prescription of this medicine.
If you interrupt treatment with PHYSIONEAL 40
Do not interrupt peritoneal dialysis without your doctor's consent. Interrupting treatment can have harmful consequences for your life.
Method of administration
Before use,
After use, check that the drained fluid is not cloudy.
Compatibility with other medicines
Your doctor may prescribe other injectable medicines to be added directly to the PHYSIONEAL 40 bag. In this case, add the medicine through the medication addition site located in the small chamber, before breaking the breakable seal between the two chambers. Use the product immediately after adding the medicine. Consult your doctor if you are unsure.
If you use more PHYSIONEAL 40 bags than you should in 24 hours
If you are administered an excessive dose of PHYSIONEAL 40, you may experience:
Contact your doctor immediately. They will inform you of what to do.
If you have any further questions about the use of this product, ask your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any of the following situations, contact your doctor or peritoneal dialysis unit immediately:
All these are serious side effects. You may need urgent medical attention.
If you experience any side effect, inform your doctor or peritoneal dialysis unit. This includes any possible side effect not listed in this leaflet.
Frequent (may affect up to 1 in 10 people):
Other side effects related to the peritoneal dialysis procedure:
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Discard PHYSIONEAL 40 as indicated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
This leaflet does not contain all the information about this medicine. If you have any doubts or are unsure about something, ask your doctor.
Composition of PHYSIONEAL 40
The mixed peritoneal dialysis solution contains the following active principles:
1.36% | 2.27% | 3.86% | |
Glucose monohydrate (g/l) | 15.0 | 25.0 | 42.5 |
equivalent to anhydrous glucose (g/l) | 13.6 | 22.7 | 38.6 |
Sodium chloride (g/l) | 5.38 | ||
Calcium chloride dihydrate (g/l) | 0.184 | ||
Magnesium chloride hexahydrate (g/l) | 0.051 | ||
Sodium bicarbonate (g/l) | 2.10 | ||
Sodium L-lactate solution (g/l) | 1.68 |
The other components are: water for injectable preparations and carbon dioxide.
The composition in mmol/l of the mixed solution is:
1.36% | 2.27% | 3.86% | |
Anhydrous glucose (mmol/l) | 75.5 | 126 | 214 |
Sodium (mmol/l) | 132 | ||
Calcium (mmol/l) | 1.25 | ||
Magnesium (mmol/l) | 0.25 | ||
Chloride (mmol/l) | 95 | ||
Bicarbonate (mmol/l) | 25 | ||
Lactate (mmol/l) | 15 |
Appearance of the Product and Package Contents
PHYSIONEAL 40 is a colorless, transparent, and sterile solution for peritoneal dialysis.
Volume | Number of units per box | Product presentation | Types of connectors |
1.51 | 5 / 6 | Single bag (DPA) | luer |
1.51 | 5 / 6 | Double bag (DPCA) | luer |
2.01 | 4 / 5 | Single bag (DPA) | luer |
2.01 | 4 / 5 | Double bag (DPCA) | luer |
2.51 | 4 / 5 | Single bag (DPA) | luer |
2.51 | 4 / 5 | Double bag (DPCA) | luer |
Only some package sizes may be marketed.
Marketing Authorization Holder
Vantive Health, S.L.
Polígono Industrial Sector 14
C/Pouet de Camilo 2
46394 Ribarroja del Turia (Valencia) Spain
Manufacturer
Vantive Manufacturing Limited
Moneen Road
Castlebar
County Mayo – Ireland
or
Bieffe Medital SpA
Via Nuova Provinciale
23034 Grosotto
Italy
Date of the Last Revision of this Leaflet: November 2018
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
Vantive and Physioneal are registered trademarks of Vantive Health Inc. or its subsidiaries